Daphne Guh

University of British Columbia

H指数:35

被引数:7,481

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International patented medicine prices: how does Canada compare to the OECD? A descriptive analysis of list prices

国际专利药品价格：加拿大与经合组织国家相比如何？——对目录价格的描述性分析

Journal of Pharmaceutical Policy and Practice

IF2.5

2026-05-280

The Patient Self-Administered Inflammatory Arthritis Detection Study

患者自行给药的炎症性关节炎检测研究

Journal of Rheumatology

IF3.4

2026-05-010

PRE

Impact of the U.S. 2025 tariff policy on Canadian pharmaceutical exports to the U.S

美国2025年关税政策对加拿大药品出口到美国的影响

Health Policy

IF3.4

2026-02-240

OAAI

Can patient-reported data improve predictions about who will be a high-need, high-cost patient in British Columbia?

患者报告的数据能否改善对不列颠哥伦比亚省高需求、高成本患者人群的预测？

Quality of Life Research

IF2.7

2025-07-090

PRE

生物仿制药政策及其对阿达木单抗、依那西普和英夫利昔单抗市场渗透的影响: 13个经合组织国家的政策综合和描述性分析

BIODRUGS

IF6.9

2025-02-250

PRE

The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis

更改参考国家对加拿大专利药品目录价格的影响: 政策分析

HEALTH POLICY

IF3.4

2024-06-010

OAAI

The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2024-05-260

OAAI

Effect of a Billing Code to Reimburse Nurse-Supported Rheumatology Care on Health Care Costs and Access: An Interrupted Time Series Analysis

ARTHRITIS CARE & RESEARCH

IF3.3

2024-03-270

OAAI

The Association of Rheumatologist Supply and Multidisciplinary Care With Timely Patient Access to Rheumatologists: Evidence From British Columbia, Canada

ARTHRITIS CARE & RESEARCH

IF3.3

2024-02-111

OAAI

Quality of life of the Canadian population using the VR-12: population norms for health utility values, summary component scores and domain scores

使用VR-12的加拿大人口的生活质量: 健康效用值，汇总成分得分和领域得分的人口规范

QUALITY OF LIFE RESEARCH

IF2.7

2023-11-082

OAAI

The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC

SUBSTANCE ABUSE AND REHABILITATION

IF5.9

2023-11-010

OAAI

A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2022-01-018

PRE

Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2021-01-014

PREAI

The Impact of Tiered-Pricing Framework on Generic Entry in Canada

分层定价框架对加拿大仿制药进入的影响

INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT

IF5.1

2020-11-166

OAAI

Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool

JOURNAL OF ADDICTION MEDICINE

IF3.2

2020-02-077

PRE

Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder

JOURNAL OF ADDICTION MEDICINE

IF3.2

2019-09-0118

OAAI

Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2019-06-0126

PREAI

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial

ADDICTION

IF5.3

2018-03-2835

PREAI

Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis

类风湿关节炎的生物疗法是否抵消了与治疗相关的资源利用和成本？文献综述与工具变量分析

CURRENT RHEUMATOLOGY REPORTS

IF3.9

2017-07-2710

PREAI

Safety profile of injectable hydromorphone and diacetylmorphine for longterm severe opioid use disorder

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2017-07-0132

PREAI

Daphne Guh

个人简介

教育背景

工作经历

荣誉奖项

研究方向